Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Donates A Second-line Defense Against China's Swelling Multidrug-resistant Tuberculosis

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - Shoring up China's arsenal against multidrug-resistant tuberculosis, Bayer AG will donate 620,000 tablets of a broad-spectrum antibiotic used as part of a second-line TB regimen
Advertisement

Related Content

Under Industry Pressure, China Blinks On Restricting Use Of Anti-infectives - Or Does It?
Bayer Says India's Natco Has No Ground For Compulsory License; Blames Lack of Drug Availability On Poor Health Infrastructure
Bayer Says India's Natco Has No Ground For Compulsory License; Blames Lack of Drug Availability On Poor Health Infrastructure
Advertisement
UsernamePublicRestriction

Register

SC078768

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel